1
|
Hori Y, Odaguchi K, Jyoyama H, Yasui K and
Mizui T: Differential effect of benexate hydrochloride betadex on
prostaglandin levels in stomach and inflammatory site in rats. Jpn
J Pharmacol. 72:183–190. 1996. View Article : Google Scholar : PubMed/NCBI
|
2
|
Pique JM, Whittle BJ and Esplugues JV: The
vasodilator role of endogenous nitric oxide in the rat gastric
microcirculation. Eur J Pharmacol. 174:293–296. 1989. View Article : Google Scholar : PubMed/NCBI
|
3
|
Ma L and Wallace JL: Endothelial nitric
oxide synthase modulates gastric ulcer healing in rats: Am J
Physiol Gastrointest. Liver Physiol. 279:G341–G346. 2000.
|
4
|
Brzozowski T, Konturek PC, Sliwowski Z,
Pajdo R, Drozdowicz D, Kwiecien S, Burnat G, Konturek SJ and Pawlik
WW: Prostaglandin/cyclooxygenase pathway in ghrelin-induced
gastroprotection against ischemia-reperfusion injury. J Pharmacol
Exp Ther. 319:477–487. 2006. View Article : Google Scholar : PubMed/NCBI
|
5
|
Dembiński A, Warzecha Z, Ceranowicz P,
Cieszkowski J, Dembiński M, Ptak-Belowska A, Kuwahara A and Kato I:
Administration of obestatin accelerates the healing of chronic
gastric ulcers in rats. Med Sci Monit. 17:BR196–BR200. 2011.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Okabe S, Roth JL and Pfeiffer CJ: A method
for experimental, penetrating gastric and duodenal ulcers in rats.
Observations on normal healing. Am J Dig Dis. 16:277–284. 1971.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Morini G and Grandi D: Methods to measure
gastric mucosal lesions in the rat. Curr Protoc Toxicol. 21:Unit
21.2. 2010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kato S, Abe Y, Konishi M, Kuroda N and
Takeuchi K: Mechanism of gastric hyperemic response during acid
secretion in rats: Relation to nitric oxide, prostaglandins, and
sensory neurons. J Clin Gastroenterol. 25(Suppl 1): S48–S55. 1997.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Moncada S, Palmer RMJ and Higgs EA: Nitric
oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev.
43:109–142. 1991.PubMed/NCBI
|
10
|
Konturek SK and Konturek PC: Role of
nitric oxide in the digestive system. Digestion. 56:1–13. 1995.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Konturek PC, Brzozowski T, Meixner H, Ptak
A, Hahn EG and Konturek SJ: Central and peripheral neural aspects
of gastroprotective and ulcer healing effects of
lipopolysaccharides. J Physiol Pharmacol. 52:611–623.
2001.PubMed/NCBI
|
12
|
Brzozowska I, Konturek PC, Brzozowski T,
Konturek SJ, Kwiecien S, Pajdo R, Drozdowicz D, Pawlik M, Ptak A
and Hahn EG: Role of prostaglandins, nitric oxide, sensory nerves
and gastrin in acceleration of ulcer healing by melatonin and its
precursor, L-tryptophan. J Pineal Res. 32:149–162. 2002. View Article : Google Scholar : PubMed/NCBI
|
13
|
Guo JS, Cheng CL and Koo MW: Inhibitory
effects of Centella asiatica water extract and asiaticoside on
inducible nitric oxide synthase during gastric ulcer healing in
rats. Planta Med. 70:1150–1154. 2004. View Article : Google Scholar : PubMed/NCBI
|
14
|
Cho SO, Lim JW, Kim KH and Kim H:
Involvement of Ras and AP-1 in Helicobacter pylori-induced
expression of COX-2 and iNOS in gastric epithelial AGS cells. Dig
Dis Sci. 55:988–996. 2010. View Article : Google Scholar : PubMed/NCBI
|
15
|
Li Y, Wang WP, Wang HY and Cho CH:
Intragastric administration of heparin enhances gastric ulcer
healing through a nitric oxide-dependent mechanism in rats. Eur J
Pharmacol. 399:205–214. 2000. View Article : Google Scholar : PubMed/NCBI
|
16
|
McCafferty DM, Mudgett JS, Swain MG and
Kubes P: Inducible nitric oxide synthase plays a critical role in
resolving intestinal inflammation. Gastroenterology. 112:1022–1027.
1997. View Article : Google Scholar : PubMed/NCBI
|
17
|
Iwasaki T and Matsunaga K: Nitric
oxide-associated vasorelaxing effect of an anti-ulcer agent,
benexate hydrochloride betadex. Drug Dev Res. 36:13–19. 1995.
View Article : Google Scholar
|
18
|
Arimoto T, Yoshikawa T, Komori Y and
Kumagai Y: Inhibition of constitutive nitric oxide synthase by
benexate. Life Sci. 59:953–959. 1996. View Article : Google Scholar : PubMed/NCBI
|
19
|
Wallace JL, McKnight W, Reuter BK and
Vergnolle N: NSAID-induced gastric damage in rats: Requirement for
inhibition of both cyclooxygenase 1 and 2. Gastroenterology.
119:706–714. 2000. View Article : Google Scholar : PubMed/NCBI
|
20
|
Tanaka A, Araki H, Hase S, Komoike Y and
Takeuchi K: Up-regulation of COX-2 by inhibition of COX-1 in the
rat: A key to NSAID-induced gastric injury. Aliment Pharmacol Ther.
16(Suppl 2): 90–101. 2002. View Article : Google Scholar : PubMed/NCBI
|
21
|
Tanaka A, Araki H, Komoike Y, Hase S and
Takeuchi K: Inhibition of both COX-1 and COX-2 is required for
development of gastric damage in response to nonsteroidal
antiinflammatory drugs. J Physiol Paris. 95:21–27. 2001. View Article : Google Scholar : PubMed/NCBI
|
22
|
Murata H, Yabe Y, Tsuji S, Tsujii M, Fu
HY, Asahi K, Eguchi H, Kawano S and Hayashi N: Gastroprotective
agent rebamipide induces cyclooxygenease-2 (COX-2) in gastric
epithelial cells. Dig Dis Sci. 50:S70–S75. 2005. View Article : Google Scholar : PubMed/NCBI
|
23
|
Gudis K and Sakamoto C: The role of
cyclooxygenase in gastric mucosal protection. Dig Dis Sci. 50(Suppl
1): S16–S23. 2005. View Article : Google Scholar : PubMed/NCBI
|
24
|
Brzozowska I, Targosz A, Sliwowski Z,
Kwiecien S, Drozdowicz D, Pajdo R, Konturek PC, Brzozowski T,
Pawlik M, Konturek SJ, et al: Healing of chronic gastric ulcers in
diabetic rats treated with native aspirin, nitric oxide
(NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor. J
Physiol Pharmacol. 55:773–790. 2004.PubMed/NCBI
|
25
|
Motilva V, de la Alarcón Lastra C,
Bruseghini L, Manuel Herrerias J and Sánchez-Fidalgo S: COX
expression and PGE(2) and PGD(2) production in experimental acute
and chronic gastric lesions. Int Immunopharmacol. 5:369–379. 2005.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Qi Z, Jie L, Haixia C and Xiaoying Z:
Effect of rebamipide on quality of peptic ulcer healing in rat. Dig
Dis Sci. 54:1876–1883. 2009. View Article : Google Scholar : PubMed/NCBI
|